Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Gross Profit (2017 - 2026)

Organogenesis Holdings has reported Gross Profit over the past 9 years, most recently at $98.6 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 3.17% year-over-year to $98.6 million; the TTM value through Dec 2025 reached $349.6 million, down 4.56%, while the annual FY2025 figure was $349.6 million, 4.56% down from the prior year.
  • Gross Profit for Q4 2025 was $98.6 million at Organogenesis Holdings, down from $114.6 million in the prior quarter.
  • Over five years, Gross Profit peaked at $114.6 million in Q3 2025 and troughed at $63.0 million in Q1 2025.
  • A 5-year average of $87.1 million and a median of $88.4 million in 2022 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: surged 90.64% in 2021 and later decreased 27.38% in 2025.
  • Year by year, Gross Profit stood at $95.3 million in 2021, then fell by 7.2% to $88.4 million in 2022, then fell by 18.69% to $71.9 million in 2023, then surged by 33.0% to $95.6 million in 2024, then grew by 3.17% to $98.6 million in 2025.
  • Business Quant data shows Gross Profit for ORGO at $98.6 million in Q4 2025, $114.6 million in Q3 2025, and $73.4 million in Q2 2025.